239 related articles for article (PubMed ID: 19072768)
1. Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis.
Chen W; Vucic E; Leupold E; Mulder WJ; Cormode DP; Briley-Saebo KC; Barazza A; Fisher EA; Dathe M; Fayad ZA
Contrast Media Mol Imaging; 2008; 3(6):233-42. PubMed ID: 19072768
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles.
Shen ZT; Zheng S; Gounis MJ; Sigalov AB
PLoS One; 2015; 10(11):e0143453. PubMed ID: 26569115
[TBL] [Abstract][Full Text] [Related]
3. Nature-inspired nanoformulations for contrast-enhanced in vivo MR imaging of macrophages.
Sigalov AB
Contrast Media Mol Imaging; 2014; 9(5):372-82. PubMed ID: 24729189
[TBL] [Abstract][Full Text] [Related]
4. Collagen-specific peptide conjugated HDL nanoparticles as MRI contrast agent to evaluate compositional changes in atherosclerotic plaque regression.
Chen W; Cormode DP; Vengrenyuk Y; Herranz B; Feig JE; Klink A; Mulder WJ; Fisher EA; Fayad ZA
JACC Cardiovasc Imaging; 2013 Mar; 6(3):373-84. PubMed ID: 23433925
[TBL] [Abstract][Full Text] [Related]
5. Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging.
Frias JC; Ma Y; Williams KJ; Fayad ZA; Fisher EA
Nano Lett; 2006 Oct; 6(10):2220-4. PubMed ID: 17034087
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Anti-Atherosclerotic Efficacy of pH-Responsively Releasable Ganglioside GM3 Delivered by Reconstituted High-Density Lipoprotein.
Rong T; Wei B; Ao M; Zhao H; Li Y; Zhang Y; Qin Y; Zhou J; Zhou F; Chen Y
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948420
[TBL] [Abstract][Full Text] [Related]
7. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
Ouimet T; Lancelot E; Hyafil F; Rienzo M; Deux F; Lemaître M; Duquesnoy S; Garot J; Roques BP; Michel JB; Corot C; Ballet S
Mol Pharm; 2012 Apr; 9(4):850-61. PubMed ID: 22352457
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Sigovan M; Kaye E; Lancelot E; Corot C; Provost N; Majd Z; Breisse M; Canet-Soulas E
Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378
[TBL] [Abstract][Full Text] [Related]
9. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-decorated reconstituted high density lipoprotein targeting atherosclerotic lesions.
Liu L; He H; Zhang M; Zhang S; Zhang W; Liu J
Biomaterials; 2014 Sep; 35(27):8002-14. PubMed ID: 24947229
[TBL] [Abstract][Full Text] [Related]
11. PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles.
Pérez-Medina C; Tang J; Abdel-Atti D; Hogstad B; Merad M; Fisher EA; Fayad ZA; Lewis JS; Mulder WJ; Reiner T
J Nucl Med; 2015 Aug; 56(8):1272-7. PubMed ID: 26112022
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium mixed-micelles: effect of the amphiphile on in vitro and in vivo efficacy in apolipoprotein E knockout mouse models of atherosclerosis.
Briley-Saebo KC; Amirbekian V; Mani V; Aguinaldo JG; Vucic E; Carpenter D; Amirbekian S; Fayad ZA
Magn Reson Med; 2006 Dec; 56(6):1336-46. PubMed ID: 17089381
[TBL] [Abstract][Full Text] [Related]
13. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
14. Comparison of synthetic high density lipoprotein (HDL) contrast agents for MR imaging of atherosclerosis.
Cormode DP; Chandrasekar R; Delshad A; Briley-Saebo KC; Calcagno C; Barazza A; Mulder WJ; Fisher EA; Fayad ZA
Bioconjug Chem; 2009 May; 20(5):937-43. PubMed ID: 19378935
[TBL] [Abstract][Full Text] [Related]
15. Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy.
Zhang M; He J; Jiang C; Zhang W; Yang Y; Wang Z; Liu J
Int J Nanomedicine; 2017; 12():533-558. PubMed ID: 28144137
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal injection improves the uptake of nanoparticle-labeled high-density lipoprotein to atherosclerotic plaques compared with intravenous injection: a multimodal imaging study in ApoE knockout mice.
Jung C; Kaul MG; Bruns OT; Dučić T; Freund B; Heine M; Reimer R; Meents A; Salmen SC; Weller H; Nielsen P; Adam G; Heeren J; Ittrich H
Circ Cardiovasc Imaging; 2014 Mar; 7(2):303-11. PubMed ID: 24357264
[TBL] [Abstract][Full Text] [Related]
17. RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probe.
Chen W; Jarzyna PA; van Tilborg GA; Nguyen VA; Cormode DP; Klink A; Griffioen AW; Randolph GJ; Fisher EA; Mulder WJ; Fayad ZA
FASEB J; 2010 Jun; 24(6):1689-99. PubMed ID: 20075195
[TBL] [Abstract][Full Text] [Related]
18. In vivo assessment of intraplaque and endothelial fibrin in ApoE(-/-) mice by molecular MRI.
Makowski MR; Forbes SC; Blume U; Warley A; Jansen CH; Schuster A; Wiethoff AJ; Botnar RM
Atherosclerosis; 2012 May; 222(1):43-9. PubMed ID: 22284956
[TBL] [Abstract][Full Text] [Related]
19. Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes.
Briley-Saebo KC; Shaw PX; Mulder WJ; Choi SH; Vucic E; Aguinaldo JG; Witztum JL; Fuster V; Tsimikas S; Fayad ZA
Circulation; 2008 Jun; 117(25):3206-15. PubMed ID: 18541740
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
